Journey Medical Corp (DERM)
5.16
+0.08
(+1.57%)
USD |
NASDAQ |
Nov 15, 16:00
5.00
-0.16
(-3.10%)
Pre-Market: 20:00
Journey Medical Free Cash Flow (Quarterly): -5.176M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -5.176M |
March 31, 2024 | -5.019M |
December 31, 2023 | -16.52M |
September 30, 2023 | 18.75M |
June 30, 2023 | 3.969M |
March 31, 2023 | -5.956M |
December 31, 2022 | -3.836M |
Date | Value |
---|---|
September 30, 2022 | -7.282M |
June 30, 2022 | -3.30M |
March 31, 2022 | -19.12M |
December 31, 2021 | -4.406M |
September 30, 2021 | -1.698M |
June 30, 2021 | -7.438M |
March 31, 2021 | 1.361M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-19.12M
Minimum
Mar 2022
18.75M
Maximum
Sep 2023
-3.976M
Average
-4.712M
Median
Free Cash Flow (Quarterly) Benchmarks
Fortress Biotech Inc | -21.84M |
Heron Therapeutics Inc | 2.94M |
Eton Pharmaceuticals Inc | 1.255M |
Elutia Inc | -4.33M |
NovaBay Pharmaceuticals Inc | -2.063M |